Solazyme and Amyris Can Cut Energy Consumption Without Producing a Drop of Fuel

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

Most companies targeting renewable fuels failed fast and hard after the Great Recession, which caused oil prices to plummet from an all-time high of $147 per barrel in July 2008 to a several-year minimum below $40 per barrel in 2009. Oil prices have since resumed their climb to triple digits, but the economics of the fuel markets haven't changed. The volumes are so massive and the selling prices are so incredibly low that few companies originally promising next-generation renewable fuels can profitably compete with petroleum-based incumbents.

Synthetic biology pioneers Solazyme (NASDAQ: SZYM  ) and Amyris (NASDAQ: AMRS  ) have surely discovered that, which is exactly why both have pivoted to smaller-volume, higher-margin specialty chemicals. It will be quite some time before either can profitably produce drop-in fuels with their industrial biotech platforms. However, that doesn't mean the pair can't help wean the world off petroleum fuels. In fact, Solazyme and Amyris can save more energy consumption with products targeting efficiency than they ever could by selling renewable fuels to consumers with their current production capacities.

Encapso targets drilling inefficiencies
Solazyme recently launched a new product line called Encapso, which consists of biodegradable lubricants that are being sold into the oil and gas drilling fluids market. When new oil and gas wells are drilled, engineers must constantly monitor the depth of the well and the amount of friction encountered by the drill head. Simply put, friction reduces the efficiency of a drilling operation and requires more torque to punch through the resistance. Engineers combat friction by adding lubricants to the bore hole, but getting the lubricants to the precise location needed is challenging. As a result, the effectiveness of lubricants is often degraded as they diffuse into the surrounding rocks and away from friction areas.

The newest product lineup from Solazyme makes those frustrations a thing of the past. As the name and producer suggest, Encapso is an oil product encapsulated within an algal cell. That comes with two major advantages. First, the encapsulated oil is only released when friction ruptures the cell. That reduces oil loss through diffusion and allows unused Encapso to be recovered and reused for other jobs.

Source: Solazyme.

Additionally, it provides engineers with a targeted friction reduction tool that reduces torque needed to break resistance. In a field test in the Three-Forks Formation, Encapso increased the rate of penetration by over 44% and allowed engineers to drill further in six days than could be achieved previously in nine days. Significantly reducing the energy needed to drill each well will give Encapso a major advantage in the competitive oil and gas drilling markets. 

Source: Solazyme.

The second advantage to an encapsulated oil is increased margin -- music to investors' ears. Solazyme puts Encapso right behind cosmetics on the margin scale, which is likely due not to increased selling prices, but to reduced production costs. Since the oil product from fermentation is meant to be encapsulated in the cell, Solazyme can skip the downstream recovery step. That also saves costs from shipping unfinished oil products from its Clinton, Iowa, facility to the Galva, Iowa, facility that separates the oil and biomass. The two facilities are 300 miles away.

Liquid Farnesene Rubber targets fuel economy
Amyris may already be producing renewable fuels in Brazil, but its biggest contribution to reducing energy consumption could be coming to a car near you by the end of this year. The company has enlisted the help of three of the world's leading tire manufacturers to replace a major component of their tires with its Liquid Farnesene Rubber and perform year-long road tests for performance and safety. Those tests should be wrapping up later this year -- and CEO John Melo isn't shy about discussing the market's enthusiasm for the product. In fact, Melo believes tire manufacturers will fund the completion of a half-completed 65,000 metric-ton-per-year facility in Brazil, which will be fully dedicated to the tire market, by 2016.

In all, 13 of the world's largest tire manufacturers are expected to use Amyris' Liquid Farnesene Rubber in new tire formulations. Why? It has a much lower viscosity than the chemical it's replacing, which increases throughput in the manufacturing process. That saves time, energy, and, most importantly, money. Better yet, new tire formulations will save considerable fuel costs for consumers by boosting fuel economy. Exact numbers haven't been released, but if the new tires are better than current-generation low-rolling resistance tires available today, they should save more than 2,600 miles' worth of fuel over their lifetime! In other words, they will likely pay for themselves in fuel costs. 

Foolish bottom line
Solazyme's Encapso and Amyris' Liquid Farnesene Rubber are just two examples of products offered by the pair that will reduce energy consumption. Indeed, both will directly target the fuels market, albeit with a carefully orchestrated approach. Solazyme will initially produce the higher value products found in a barrel of oil -- and products not within reach of today's refineries -- for blending into larger volumes of fuels, while Amyris will soon produce niche jet fuel once it gains approval later this year. Until they harness the power of their platforms for directly producing fuels, however, investors should realize the power of non-fuel products and their ability to reduce energy consumption. Fuel not required.

OPEC is absolutely terrified of this game-changer
One day, OPEC will be forced to adjust to industrial biotech platforms enabled by synthetic biology, such as those developed by Solazyme and Amyris. While that day could arrive much sooner with non-fuel products, are they something that keeps OPEC awake at night now? An exclusive, brand-new Motley Fool report reveals the company we're calling OPEC's Worst Nightmare. Just click here to uncover the name of this industry-leading stock, and join Warren Buffett in his quest for a veritable landslide of profits!

Read/Post Comments (5) | Recommend This Article (6)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On April 21, 2014, at 1:51 PM, FoolishQC wrote:

    Why do you like amrs so much?!! I have lost money because you keep comparing them to szym.

    Those are my losses and my fault. I am never listening to your advice on amrs again. I know better now.

  • Report this Comment On April 21, 2014, at 2:33 PM, TMFBlacknGold wrote:


    I have not compared Amyris to Solazyme; the businesses are pretty unique (Solazyme produces oils, Amyris produces organisms). I've written extensively about the circumstances surrounding Amyris at the time of my blogging for TMF in 2012. Reality dampened previously bullish outlooks on the company in 2012 and 2013, but the company has focused on engineering principles to smooth out earlier production troubles. Thus, the long term potential for value creation remains in place. I'd also like to think I've grown quite a bit as a technical writer and investor since then.

    Besides, if you purchased shares of Amyris and Solazyme after April 2012 (when I began focusing on the blog network) you would have a much better chance of being positive with the former and in the red with the latter. Couldn't the case be made that Amyris offers better potential with a valuation of roughly 1/3 that of Solazyme, given the commercialization plans?

    Best wishes,


  • Report this Comment On April 21, 2014, at 3:38 PM, FoolishQC wrote:

    Amrs offers better potential??? Now I feel like an idiot having listened to you.

    Amrs needs money to expand. I am out now, so you can be the one paying for it. Pay amrs directly or through Total with their gouging convertible debt offers.

    You go write your little articles, sonny. I am one less fool to get suckered by your words on that company. You young people look at low share prices and get all googly-eyed.

  • Report this Comment On April 23, 2014, at 12:43 AM, Tgar13 wrote:

    Dear Foolish QC

    While I haven't always agreed with Maxxwell (he is certainly getting stronger as time goes by) it doesn't mean I or anyone as the right to be disrespectful to him for expressing his ideas

    If you can't take responsibility for your own due diligence please invest in index funds and stop posting

    Tony G

  • Report this Comment On April 25, 2014, at 2:10 PM, TMFBlacknGold wrote:


    I'm looking at current market valuation, not share price, and accounting for potential future growth opportunities that have a relatively good chance of materializing. I have never said there aren't risks and will continue to do my best to educate investors about the risks and rewards of an investment.

    Best wishes,


Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2921422, ~/Articles/ArticleHandler.aspx, 8/30/2015 4:08:37 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Maxx Chatsko

Maxx has been a contributor to since 2013. He's currently a graduate student at Carnegie Mellon University merging synthetic biology with materials science & engineering. His primary coverage for TMF includes renewable energy, renewable fuels, and synthetic biology. Follow him on Twitter to keep pace with developments with engineering biology.

Today's Market

updated 1 day ago Sponsored by:
DOW 16,643.01 -11.76 -0.07%
S&P 500 1,988.87 1.21 0.06%
NASD 4,828.33 15.62 0.32%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

8/28/2015 3:59 PM
AMRS $1.69 Down -0.01 -0.59%
SZYM $2.52 Up +0.14 +5.88%
Solazyme CAPS Rating: ***